Griffin GD, Calle EE, Morris MD, Long KY, Schuffman SS, Mitchell WM. Inhibition of murine interferon production following in vivo administration of benzo[a]pyrene.
JOURNAL OF INTERFERON RESEARCH 1986;
6:115-21. [PMID:
2425012 DOI:
10.1089/jir.1986.6.115]
[Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
To investigate whether alteration in interferon (IFN) production might serve as a biomarker for certain toxic chemical exposures, an in vivo mouse model system was studied. Female C3H mice were injected intraperitoneally with varying doses of benzo[a]pyrene (BP), and at various times subsequent to this treatment, serum IFN levels, following Sendai virus induction, were determined by a cytopathic effect inhibition assay. Doses of 4.6 mg/mouse (180 mg/kg body weight) caused a significant depression in IFN production at 12, 48, and 120 h after BP administration. Doses of 0.46 mg also produced significant decreases at 48 h following exposure. At 48 h post-BP treatment, the reduction in serum IFN titers in treated animals relative to controls was: 62% for the 0.46-mg dose, and 94% for the 4.6-mg dose. These results indicate that systemic administration of BP can significantly depress the whole-animal IFN response to viral stimulation, and that such depression can persist for a rather extended period at certain dose levels.
Collapse